EAM Investors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,858
| Closed | -$2.34M | – | 305 |
|
|
2024
Q3 | $2.34M | Sell |
12,858
-13,426
| -51% | -$2.44M | 0.35% | 134 |
|
|
2024
Q2 | $4.83M | Sell |
26,284
-151
| -0.6% | -$27.7K | 0.78% | 15 |
|
|
2024
Q1 | $4.7M | Buy |
+26,435
| New | +$4.7M | 0.73% | 22 |
|
|
2023
Q4 | – | Sell |
-16,091
| Closed | -$1.87M | – | 321 |
|
|
2023
Q3 | $1.87M | Buy |
16,091
+377
| +2% | +$43.7K | 0.36% | 116 |
|
|
2023
Q2 | $1.84M | Sell |
15,714
-9,013
| -36% | -$1.06M | 0.34% | 120 |
|
|
2023
Q1 | $1.98M | Sell |
24,727
-8,518
| -26% | -$682K | 0.39% | 111 |
|
|
2022
Q4 | $2.63M | Sell |
33,245
-194
| -0.6% | -$15.4K | 0.55% | 53 |
|
|
2022
Q3 | $2.33M | Buy |
33,439
+2,809
| +9% | +$196K | 0.51% | 73 |
|
|
2022
Q2 | $2.01M | Sell |
30,630
-3,248
| -10% | -$213K | 0.49% | 68 |
|
|
2022
Q1 | $2.25M | Sell |
33,878
-989
| -3% | -$65.8K | 0.42% | 80 |
|
|
2021
Q4 | $2.44M | Buy |
+34,867
| New | +$2.44M | 0.4% | 73 |
|
|
2020
Q2 | – | Sell |
-69,430
| Closed | -$3M | – | 288 |
|
|
2020
Q1 | $3M | Buy |
69,430
+3,967
| +6% | +$172K | 0.93% | 10 |
|
|
2019
Q4 | $3.63M | Sell |
65,463
-22,451
| -26% | -$1.24M | 0.8% | 18 |
|
|
2019
Q3 | $3.05M | Buy |
87,914
+6,467
| +8% | +$225K | 0.81% | 20 |
|
|
2019
Q2 | $3.28M | Buy |
81,447
+58,626
| +257% | +$2.36M | 0.8% | 18 |
|
|
2019
Q1 | $751K | Sell |
22,821
-10,204
| -31% | -$336K | 0.18% | 212 |
|
|
2018
Q4 | $686K | Buy |
+33,025
| New | +$686K | 0.19% | 217 |
|